Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Ciliary neurotrophic factor infused intracerebroventricularly shows reduced catabolic effects when linked to the TAT protein transduction domain

Full text
Author(s):
Vieira, Andre S. [1] ; Rezende, Alexandre C. S. [1] ; Grigoletto, Jessica [2] ; Rogerio, Fabio [1] ; Velloso, Licio A. [3] ; Skaper, Stephen D. [4] ; Negro, Alessandro [2] ; Langone, Francesco [1]
Total Authors: 8
Affiliation:
[1] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Campinas, SP - Brazil
[2] Univ Padua, CRIBI, Dept Vet Sci, Padua - Italy
[3] Univ Estadual Campinas, Dept Internal Med, Campinas, SP - Brazil
[4] Univ Padua, CRIBI, Dept Pharmacol & Anesthesiol, Padua - Italy
Total Affiliations: 4
Document type: Journal article
Source: Journal of Neurochemistry; v. 110, n. 5, p. 1557-1566, SEP 2009.
Web of Science Citations: 16
Abstract

Ciliary neurotrophic factor (CNTF) regulates the differentiation and survival of a wide spectrum of developing and adult neurons, including motor neuron loss after injury. We recently described a cell-penetrant recombinant human CNTF (rhCNTF) molecule, formed by fusion with the human immunodeficiency virus-1 transactivator of transcription (TAT) protein transduction domain (TAT-CNTF) that, upon subcutaneous administration, retains full neurotrophic activity without cytokine-like side-effects. Although the CNTF receptor is present in hypothalamic nuclei, which are involved in the control of energy, rhCNTF but not TAT-CNTF stimulates signal transducers and activators of transcription 3 phosphorylation in the rat hypothalamus after subcutaneous administration. This could be due limited TAT-CNTF distribution in the hypothalamus and/or altered intracellular signaling by the fusion protein. To explore these possibilities, we examined the effect of intracerebroventricular administration of TAT-CNTF in male adult rats. TAT-CNTF-induced weight loss, although the effect was smaller than that seen with either rhCNTF or leptin (which exerts CNTF-like effects via its receptor). In contrast to rhCNTF and leptin, TAT-CNTF neither induced morphological changes in adipose tissues nor increased uncoupling protein 1 expression in brown adipose tissue, a characteristic feature of rhCNTF and leptin. Acute intracerebroventricular administration of TAT-CNTF induced a less robust phosphorylation of signal transducers and activators of transcription 3 in the hypothalamus, compared with rhCNTF. The data show that fusion of a protein transduction domain may change rhCNTF CNS distribution, while further strengthening the utility of cell-penetrating peptide technology to neurotrophic factor biology beyond the neuroscience field. (AU)